Author - Press Release

Abbott to acquire Exact Sciences

Invert launches Invert Assist, an AI-powered analysis interface built for bioprocess

Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment

Tempus Announces the Acquisition of Paige

10x Genomics to Acquire Scale Biosciences

Ultima Genomics Selected to Support the World’s Largest Proteomics Studies to Date Led by Regeneron Genetics Center

Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company’s multiomics strategy

23andMe Reaches Agreement for Sale of Business to TTAM Research Institute Following Final Round of Bidding in Court-Approved Sale Process

Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis

Roche announces new collaboration with Broad Clinical Labs to accelerate adoption of cutting-edge SBX sequencing technology

Regeneron Enters into Asset Purchase Agreement to Acquire 23andMe® for $256 Million; Plans to Maintain Consumer Genetics Business and Advance Shared Goals of Improving Human Health and Wellness

Oracle, Cleveland Clinic, and G42 Announce Strategic Partnership to Launch AI-Based Global Healthcare Delivery Platform

QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software

AI model trained on de-identified data from 57 million people

GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale

Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery

Copyright © 2026. enlighenbio LLC. All rights reserved.